- Datum05.05.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Altan Cantürk
Moderator
Palvella Therapeutics Inc. Aktie
Verkaufen
Kaufen
Palvella Therapeutics Inc. Chart
Palvella Therapeutics Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Baader | VK | |||||
| gettex | VK | |||||
| Nasdaq | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
1,54 %
Intraday
-3,66 %
1 Woche
2,00 %
1 Monat
103,83 %
Seit Jahresbeginn
120,76 %
1 Jahr
-88,84 %
3 Jahre
-88,46 %
5 Jahre
Passender Service zu Palvella Therapeutics Inc.
Webinar zu Palvella Therapeutics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)6,200-29,270
- Jahrestief / Hoch ($)11,280-29,270
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Palvella Therapeutics Inc.
Keine Dividenden verfügbar
Termine von Palvella Therapeutics Inc.
Keine aktuellen Termine
Beschreibung
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States.
